성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,775명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
Multisystem Organ Failure | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Multisystem Organ Failure

NCLEX Review Guide: Multisystem Organ Failure

Pathophysiology of Multisystem Organ Failure

Definition and Mechanism

  • Multisystem Organ Failure (MSOF), also known as Multiple Organ Dysfunction Syndrome (MODS), refers to the progressive dysfunction of two or more organ systems resulting from an uncontrolled inflammatory response to a severe illness or injury. The cascade typically begins with an initial insult (infection, trauma, burns) that triggers systemic inflammatory response syndrome (SIRS).
  • The pathophysiological sequence involves release of inflammatory mediators (cytokines, complement proteins, and coagulation factors) that cause widespread endothelial damage, microcirculatory dysfunction, cellular hypoxia, and ultimately organ failure.

Key Points

  • MSOF represents a continuum rather than a single event, with progressive deterioration of organ function.
  • Primary MODS results directly from an insult; secondary MODS develops as a consequence of the systemic inflammatory response.

Etiology and Risk Factors

  • Common precipitating factors include sepsis (most common), trauma, burns, pancreatitis, major surgery, shock states, and massive transfusions. Each of these conditions can initiate the inflammatory cascade that leads to MSOF.
  • Risk factors that increase susceptibility include advanced age, immunocompromised status, malnutrition, pre-existing organ dysfunction, and genetic predisposition to exaggerated inflammatory responses.

Key Points

  • Sepsis remains the leading cause of MSOF, with mortality rates of 30-50% when multiple organs are involved.
  • Early identification of at-risk patients is crucial for preventive interventions.

Clinical Manifestations by System

Respiratory System Failure

  • Manifests as Acute Respiratory Distress Syndrome (ARDS), characterized by bilateral pulmonary infiltrates, severe hypoxemia (PaO₂/FiO₂ ratio ≤ 300 mmHg), and non-cardiogenic pulmonary edema. Patients typically present with tachypnea, dyspnea, decreased oxygen saturation, and increased work of breathing.
  • Progressive respiratory failure leads to ventilation-perfusion mismatching, decreased lung compliance, and refractory hypoxemia requiring mechanical ventilation with high PEEP and FiO₂ settings.

Key Points

  • Respiratory failure is often the first manifestation of MSOF and may precede other organ system failures.
  • Lung-protective ventilation strategies are essential to prevent ventilator-induced lung injury.

Cardiovascular System Failure

  • Presents as distributive shock with hypotension (systolic BP < 90 mmHg or MAP < 65 mmHg) despite adequate fluid resuscitation, requiring vasopressor support. Cardiac dysfunction includes decreased contractility, tachycardia, and reduced systemic vascular resistance.
  • Myocardial depression occurs due to circulating inflammatory mediators, resulting in decreased ejection fraction, ventricular dilation, and impaired response to catecholamines.

Key Points

  • Cardiovascular failure in MSOF involves both macrocirculatory (hypotension) and microcirculatory (tissue perfusion) dysfunction.
  • Elevated serum lactate (> 2 mmol/L) indicates tissue hypoperfusion even when vital signs appear stable.

Renal System Failure

  • Manifests as Acute Kidney Injury (AKI), characterized by decreased urine output (< 0.5 mL/kg/hr for ≥ 6 hours), elevated serum creatinine (increase of ≥ 0.3 mg/dL or ≥ 1.5 times baseline), and accumulation of nitrogenous waste products.
  • Pathophysiology involves renal hypoperfusion, direct cytokine-mediated tubular damage, and microvascular thrombosis, leading to decreased glomerular filtration rate and tubular dysfunction.

Key Points

  • RIFLE criteria (Risk, Injury, Failure, Loss, End-stage) or KDIGO staging help classify the severity of AKI.
  • Renal replacement therapy may be required for severe AKI with fluid overload, electrolyte abnormalities, or uremic complications.

Hepatic System Failure

  • Characterized by hyperbilirubinemia (total bilirubin > 2 mg/dL), elevated liver enzymes (AST, ALT), decreased albumin synthesis, and impaired coagulation (increased PT/INR). Clinical manifestations include jaundice, hepatomegaly, and altered mental status due to hepatic encephalopathy.
  • Hepatic dysfunction results from decreased perfusion, direct cytokine-mediated hepatocellular injury, and cholestasis due to altered bile transport.

Key Points

  • Liver dysfunction affects drug metabolism, necessitating dose adjustments for hepatically cleared medications.
  • Coagulopathy from decreased synthesis of clotting factors increases bleeding risk and may require correction with blood products.

Hematologic System Failure

  • Presents as disseminated intravascular coagulation (DIC) with thrombocytopenia (platelets < 100,000/μL), prolonged coagulation times (PT, aPTT), decreased fibrinogen, and elevated D-dimer levels. Patients may exhibit both bleeding and thrombotic complications.
  • Bone marrow suppression from inflammatory mediators leads to anemia and leukopenia, further compromising oxygen delivery and immune function.

Key Points

  • DIC represents a severe derangement of coagulation with simultaneous clotting and bleeding tendencies.
  • Monitoring of complete blood count, coagulation parameters, and fibrin degradation products is essential for early detection.

Neurologic System Failure

  • Manifests as encephalopathy with altered mental status ranging from mild confusion to coma. Changes in level of consciousness, cognitive function, and behavior may fluctuate throughout the day.
  • Pathophysiology involves cerebral hypoperfusion, blood-brain barrier disruption, neuroinflammation, neurotransmitter imbalances, and metabolic derangements from other organ failures.

Key Points

  • Glasgow Coma Scale (GCS) and CAM-ICU (Confusion Assessment Method for ICU) are validated tools for neurologic assessment.
  • Neurologic dysfunction may be an early indicator of deterioration and is associated with increased mortality.

Gastrointestinal System Failure

  • Presents as ileus, mucosal barrier dysfunction, malabsorption, and increased gut permeability. Clinical manifestations include abdominal distention, absent bowel sounds, feeding intolerance, and diarrhea.
  • Gut dysfunction contributes to bacterial translocation, which may perpetuate the systemic inflammatory response and lead to secondary infections.

Key Points

  • The gut has been referred to as the "motor" of MSOF due to its role in perpetuating inflammation.
  • Early enteral nutrition, when feasible, helps maintain gut integrity and modulate the inflammatory response.

Endocrine System Failure

  • Characterized by relative adrenal insufficiency, insulin resistance with hyperglycemia, sick euthyroid syndrome, and vasopressin deficiency. These endocrine derangements contribute to hemodynamic instability and metabolic dysfunction.
  • Altered hormone production, receptor sensitivity, and signaling pathways impair the body's adaptive responses to stress and contribute to catabolism.

Key Points

  • Glycemic control is important, with target blood glucose levels typically 140-180 mg/dL in critically ill patients.
  • Corticosteroid supplementation may be beneficial in patients with vasopressor-dependent shock and suspected adrenal insufficiency.

Nursing Assessment and Diagnosis

Comprehensive Assessment

  • Perform systematic assessment of all organ systems with frequent monitoring of vital signs, hemodynamic parameters, fluid balance, laboratory values, and organ function tests. Pay particular attention to trends rather than isolated values.
  • Use validated scoring systems such as Sequential Organ Failure Assessment (SOFA), Multiple Organ Dysfunction Score (MODS), or Acute Physiology and Chronic Health Evaluation (APACHE) to quantify severity and predict outcomes.

Key Points

  • SOFA score evaluates six organ systems (respiratory, cardiovascular, hepatic, coagulation, renal, and neurological) with scores ranging from 0-4 for each system.
  • An increase in SOFA score of ≥ 2 points indicates organ dysfunction and is associated with increased mortality.

Priority Nursing Diagnoses

  • Impaired Gas Exchange related to ventilation-perfusion mismatch, alveolar-capillary membrane changes, and decreased lung compliance as evidenced by hypoxemia, tachypnea, and abnormal arterial blood gases.
  • Decreased Cardiac Output related to myocardial depression, altered preload/afterload, and dysrhythmias as evidenced by hypotension, tachycardia, and decreased peripheral perfusion.
  • Deficient Fluid Volume or Excess Fluid Volume related to capillary leak, altered fluid distribution, and renal dysfunction as evidenced by abnormal fluid balance, edema, and hemodynamic instability.
  • Risk for Infection related to immunosuppression, invasive procedures, and disrupted tissue integrity as evidenced by leukocytosis/leukopenia and positive cultures.
  • Impaired Tissue Integrity related to immobility, poor nutrition, and altered peripheral perfusion as evidenced by skin breakdown and impaired wound healing.

Key Points

  • Nursing diagnoses should be prioritized based on immediate life-threatening conditions and the patient's specific organ dysfunctions.
  • Regular reassessment and revision of nursing diagnoses is essential as the patient's condition evolves.

Management Principles

Early Recognition and Intervention

  • Implement early screening and monitoring protocols to identify patients at risk for or developing MSOF. Utilize early warning scoring systems and rapid response teams to intervene before organ dysfunction becomes established.
  • Address the underlying cause (source control) through appropriate antimicrobial therapy for infection, surgical intervention for trauma or necrotic tissue, and management of inflammatory conditions.

Clinical Scenario: A 68-year-old male presents to the emergency department with fever, tachycardia, hypotension, and confusion following urinary catheterization 3 days ago. Initial assessment reveals temperature 39.2°C, HR 118, BP 88/45, RR 24, and SpO₂ 92% on room air. The nurse recognizes these as SIRS criteria and potential early sepsis, immediately notifies the provider, obtains blood cultures, initiates fluid resuscitation, and prepares for antibiotic administration, preventing progression to full MSOF.

Key Points

  • The "golden hour" concept applies to MSOF—early intervention within the first hours can significantly improve outcomes.
  • Follow established protocols such as Surviving Sepsis Campaign guidelines for early recognition and management.

Hemodynamic Support

  • Administer fluid resuscitation with crystalloids (typically 30 mL/kg within the first 3 hours for sepsis-induced hypoperfusion) guided by dynamic parameters of fluid responsiveness (passive leg raise, pulse pressure variation, stroke volume variation).
  • Initiate vasopressor therapy if hypotension persists despite adequate fluid resuscitation, with norepinephrine as the first-line agent to maintain MAP ≥ 65 mmHg, followed by vasopressin or epinephrine as needed.
Vasopressors must be administered through a central venous catheter. Monitor for extravasation if peripheral administration is temporarily necessary, as tissue necrosis can occur.

Key Points

  • Balance fluid administration carefully—insufficient resuscitation leads to tissue hypoperfusion while excessive fluids contribute to edema and organ dysfunction.
  • Use inotropic support (dobutamine) when cardiac dysfunction with low cardiac output persists despite adequate preload and blood pressure.

Respiratory Support

  • Provide oxygen therapy to maintain SpO₂ ≥ 94% (88-92% in patients with COPD). Escalate from nasal cannula to high-flow nasal cannula or non-invasive ventilation as needed, with continuous monitoring for signs of respiratory deterioration.
  • Implement mechanical ventilation with lung-protective strategies for ARDS, including low tidal volumes (4-6 mL/kg predicted body weight), plateau pressures < 30 cmH₂O, appropriate PEEP to prevent atelectrauma, and permissive hypercapnia.
  1. Position the patient in a semi-recumbent position (30-45° head elevation) to reduce the risk of ventilator-associated pneumonia.
  2. Consider prone positioning for 12-16 hours per day in patients with severe ARDS (PaO₂/FiO₂ < 150) to improve oxygenation.
  3. Implement a daily sedation interruption protocol to assess neurological status and readiness for ventilator weaning.
  4. Perform spontaneous breathing trials in stable patients to evaluate readiness for extubation.
  5. Maintain endotracheal cuff pressure between 20-30 cmH₂O to prevent microaspiration while avoiding tracheal injury.

Key Points

  • Ventilator-induced lung injury can exacerbate MSOF; adherence to lung-protective strategies is essential.
  • Daily assessment of readiness for liberation from mechanical ventilation reduces complications associated with prolonged ventilation.

Renal Support

  • Optimize renal perfusion through adequate hemodynamic support and avoidance of nephrotoxic agents. Monitor fluid balance, electrolytes, and renal function parameters (BUN, creatinine, urine output) at least daily.
  • Initiate renal replacement therapy (RRT) for severe AKI with refractory acidosis (pH < 7.15), hyperkalemia (K+ > 6.5 mEq/L), uremia (BUN > 100 mg/dL), fluid overload (> 10% of body weight), or oliguria/anuria unresponsive to diuretics.

Indications for Renal Replacement Therapy: "A CREED"

  • Acidosis (severe, refractory)
  • Cations (hyperkalemia)
  • Refractory fluid overload
  • Elimination of toxins
  • End-stage renal disease
  • Drug overdose (dialyzable)

Key Points

  • Continuous renal replacement therapy (CRRT) is often preferred in hemodynamically unstable patients as it provides gradual fluid removal with less cardiovascular stress.
  • Drug dosing requires adjustment based on renal function and RRT modality to prevent under- or over-dosing.

Nutritional Support

  • Initiate early enteral nutrition within 24-48 hours of admission if the gastrointestinal tract is functional. Start with trophic feeding (10-20 mL/hr) and advance as tolerated, using post-pyloric feeding in patients with high aspiration risk or gastric intolerance.
  • Provide parenteral nutrition when enteral feeding is contraindicated or insufficient to meet nutritional requirements after 7 days. Calculate caloric needs based on indirect calorimetry or predictive equations (25-30 kcal/kg/day), with protein requirements of 1.2-2.0 g/kg/day.

Key Points

  • Enteral nutrition helps maintain gut barrier function, reduces bacterial translocation, and modulates the inflammatory response.
  • Monitor for feeding intolerance (high gastric residuals, abdominal distention, vomiting) and adjust feeding strategy accordingly.

Infection Control and Antimicrobial Therapy

  • Implement infection prevention practices including hand hygiene, barrier precautions, aseptic technique for invasive procedures, and care bundles for devices (central lines, urinary catheters, ventilators). Remove unnecessary invasive devices promptly.
  • Administer appropriate antimicrobial therapy based on suspected source, local resistance patterns, and patient factors. Obtain cultures before initiating antibiotics when possible, and reassess therapy at 48-72 hours for de-escalation based on culture results and clinical response.
Delay in appropriate antimicrobial therapy for septic shock increases mortality by approximately 7.6% for each hour of delay. Administer broad-spectrum antibiotics within 1 hour of recognition.

Key Points

  • Antimicrobial stewardship (appropriate selection, dosing, route, and duration) is essential to maximize efficacy while minimizing resistance and toxicity.
  • Daily assessment for opportunities to de-escalate antimicrobial therapy based on culture results and clinical improvement.

Supportive Care

  • Implement glycemic control with insulin therapy targeting blood glucose levels of 140-180 mg/dL. Monitor blood glucose every 1-2 hours initially, then every 4 hours when stable.
  • Provide stress ulcer prophylaxis with proton pump inhibitors or H₂ receptor antagonists for patients with risk factors (mechanical ventilation > 48 hours, coagulopathy, history of GI bleeding).
  • Administer venous thromboembolism (VTE) prophylaxis with pharmacological agents (unfractionated or low molecular weight heparin) unless contraindicated, combined with mechanical methods (sequential compression devices) when appropriate.
  • Implement early mobility and rehabilitation programs to prevent ICU-acquired weakness, delirium, and complications of immobility. Progress from passive range of motion to active exercises and ambulation as tolerated.

Key Points

  • Delirium prevention strategies include orientation protocols, sleep promotion, early mobility, and minimization of deliriogenic medications.
  • Pain assessment and management should be prioritized even in sedated or non-verbal patients, using validated tools like the CPOT or BPS.

Summary of Key Points

  • MSOF Pathophysiology: Results from an uncontrolled inflammatory response to an initial insult, with progressive dysfunction of multiple organ systems. Sepsis remains the leading cause, with mortality rates increasing with each additional organ failure.
  • Early Recognition: Prompt identification of at-risk patients and early intervention are crucial for preventing progression of organ dysfunction. Use validated scoring systems (SOFA, MODS) to quantify severity and guide management.
  • Management Principles: Treatment focuses on addressing the underlying cause, supporting organ function, preventing complications, and providing comprehensive supportive care. A multidisciplinary approach is essential.
  • Hemodynamic Support: Guided fluid resuscitation followed by vasopressors if needed to maintain tissue perfusion. Avoid both under-resuscitation and fluid overload.
  • Respiratory Support: Oxygen therapy and mechanical ventilation with lung-protective strategies to prevent ventilator-induced lung injury. Consider prone positioning for severe ARDS.
  • Renal Support: Optimize renal perfusion, avoid nephrotoxins, and initiate RRT when indicated for severe AKI. Adjust medication dosing based on renal function.
  • Nutritional Support: Early enteral nutrition preferred when possible, with parenteral nutrition reserved for contraindications or inadequate enteral intake.
  • Infection Control: Rigorous prevention practices, prompt source control, and appropriate antimicrobial therapy with regular reassessment for de-escalation.
  • Supportive Care: Includes glycemic control, stress ulcer and VTE prophylaxis, early mobility, delirium prevention, and pain management.
  • Prognosis: Mortality increases with the number of failing organs, severity of dysfunction, and duration of organ failure. Age, comorbidities, and nature of the precipitating event also affect outcomes.

Commonly Confused Points

SIRS vs. Sepsis vs. Septic Shock vs. MSOF

Condition Definition Clinical Criteria Management Focus
SIRS (Systemic Inflammatory Response Syndrome) Generalized inflammatory response that can be triggered by infectious or non-infectious causes ≥ 2 of: Temperature > 38°C or < 36°C, HR > 90, RR > 20 or PaCO₂ < 32 mmHg, WBC > 12,000/μL or < 4,000/μL or > 10% bands Identify and address underlying cause, supportive care
Sepsis Life-threatening organ dysfunction caused by a dysregulated host response to infection Suspected or documented infection plus acute increase in SOFA score ≥ 2 points (or qSOFA ≥ 2 for screening) Early antibiotics, source control, fluid resuscitation
Septic Shock Subset of sepsis with circulatory, cellular, and metabolic abnormalities associated with higher mortality Sepsis with persistent hypotension requiring vasopressors to maintain MAP ≥ 65 mmHg AND serum lactate > 2 mmol/L despite adequate fluid resuscitation Aggressive hemodynamic support, vasopressors, source control
MSOF/MODS Progressive dysfunction of two or more organ systems that cannot maintain homeostasis without intervention Evidence of dysfunction in multiple organ systems as measured by clinical, laboratory, and physiologic parameters Organ support therapies, treating underlying cause, preventing further dysfunction

Key Points

  • SIRS can occur without infection, while sepsis requires the presence of infection.
  • MSOF can result from sepsis (most common) but also from non-infectious causes like trauma, burns, or pancreatitis.

Types of Shock in MSOF

Type of Shock Pathophysiology Hemodynamic Profile Clinical Presentation Treatment Focus
Distributive (Septic) Shock Vasodilation, increased capillary permeability, myocardial depression ↓ SVR, ↑ or normal CO initially, then ↓ CO late, ↓ BP Warm extremities initially, bounding pulses, wide pulse pressure, later cool extremities Fluid resuscitation, vasopressors, source control
Cardiogenic Shock Decreased myocardial contractility due to cytokine-mediated depression ↓ CO, ↑ SVR, ↓ BP, ↑ PCWP Cool extremities, weak pulses, narrow pulse pressure, JVD, pulmonary edema Inotropic support, preload/afterload optimization
Hypovolemic Shock Inadequate circulating volume due to fluid losses or third-spacing ↓ CO, ↑ SVR, ↓ BP, ↓ PCWP Cool extremities, weak pulses, flat neck veins, poor skin turgor Fluid resuscitation, blood products if hemorrhagic
Obstructive Shock Mechanical obstruction to cardiac filling or output (e.g., tension pneumothorax, cardiac tamponade) ↓ CO, ↑ SVR, ↓ BP, variable PCWP Depends on cause: JVD, pulsus paradoxus, unilateral breath sounds Remove obstruction (e.g., needle decompression, pericardiocentesis)

Key Points

  • Multiple types of shock can coexist in MSOF (e.g., septic shoc

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.